Adjuvant Tamoxifen: The Risks Versus the Benefits of Long-Term Therapy

By Schlesinger K.W.   Vogel V.G.  

American Journal of Cancer, Vol. 1, Iss. 6, 2002-01 ,pp. : 375-386

Adis International

Access to resources Recommend Favorite

Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

By Rutqvist Lars   Johansson Hemming   Group on behalf of the Stockholm Breast Cancer Study  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 133-145

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant!^© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

By Paridaens Robert   Gelber Shari   Cole Bernard   Gelber Richard   Thürlimann Beat   Price Karen   Holmberg Stig   Crivellari Diana   Coates Alan   Goldhirsch Aron  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 303-310

Springer Publishing Company

Access to resources Recommend Favorite

Co-expression of estrogen receptor α and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

By Søiland Håvard   Skaland Ivar   Varhaug Jan Erik   Kørner Hartwig   Janssen Emiel   Gudlaugsson Einar   Baak Jan   Søreide Jon Arne  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 514-521

Informa Healthcare

Access to resources Recommend Favorite